Stay updated with breaking news from Company Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ông Trần Lưu Quang - Bí thư Thành ủy Hải Phòng, cam kết toàn tâm toàn ý cùng Ban Chấp hành Đảng bộ xây dựng một tập thể lãnh đạo đoàn kết nhất trí, thống nhất hành động vì sự phát triển và bình yên của thành phố Hải Phòng.
May 1, 2021 Purpose and scope of role The Business Development role focuses on a primary driver of the business’s growth being the conversion of assets under advice into assets under management (AUM). This is traditionally achieved through two channels: The provision of Para-planning support (Approved Advice Models) that is deployed into Advisor practices to improve efficiencies and planning outcomes for partners through the adoption of Approved Advice Program. In addition, to grow AUM through the marketing and direct activation of investment capabilities and solutions to Advisor Clients ...
Key partnership with Fresenius Humacyte was founded in 2004, and the Biotechnology Center provided it a $150,000 Small Business Research Loan in 2006. Since then Humacyte has raised nearly $480 million, including a $150 million equity investment from Fresenius Medical Care, the world’s leading provider of products and services for patients with renal diseases and for surgical care centers. “Humacyte is a world-class regenerative medicine company developing bioengineered tissues to treat unmet medical needs,” said Vivian Doelling, Ph.D., NCBiotech’s vice president of Emerging Company D...
Humacyte Set to Go Public, Raise $175 Million from Top-tier Investors Durham-based Humacyte, a regenerative medicine company that received start-up support from the North Carolina Biotechnology Center 15 years ago, is going public in a novel deal that will give it a market capitalization of $1.1 billion. Humacyte and Alpha Healthcare Acquisition Corp., a special purpose acquisition company (SPAC) based in New York, have signed a business-combination agreement to take Humacyte public, along with a $175M PIPE financing agreement. “We are very pleased to have support from top-tier investors an...
David (Dave) Pell (Head of Sales & Marketing, aged 58). Dave, who joined the Company in January 2020, has over 30 years' experience working in key sales and commercial roles in technology-based businesses. He has run a number of global sales organisations for the largest global IT and technology companies, commercial operations for BT Global Services, and has headed advanced technology divisions at QinetiQ, where he led the focus on technology transition and commercialisation, with a particular focus on applications in energy markets. Stuart Paterson (Head of Operations, age...